Department of Gastroenterology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430077, China.
Department of Internal Medicine and Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, 430071, China.
Biochem Genet. 2023 Oct;61(5):2092-2115. doi: 10.1007/s10528-023-10361-5. Epub 2023 Mar 21.
Immunogenic cell death (ICD) induces anti-tumor immunity and aids in dismantling the immunosuppressive immune microenvironment (TME), which belongs to a type of regulated cell death. The differentiation of gastric cancer (GC) subtypes and the discovery of prognostic biomarkers are crucial for its treatment because GC is a disease that is both highly heterogeneous and aggressive. However, although the induction of ICD in tumor cells is associated with a favorable prognosis, the exact mechanism of its role in GC remains unclear. Transcriptome profiling data and clinical data of GC patients were retrieved from The Cancer Genome Atlas (TCGA) database. Herein, patients were classified with the consensus clustering algorithm, and the associated biological functions and immune microenvironment infiltration were explored based on the expression of ICD-associated genes. A risk score signature consisting of 11 ICD-related genes was established via the least absolute shrinkage and selection operator regression (LASSO) method. We have retrieved similar studies in recent years and compared them with our study using the time-dependent receiver operating characteristic (ROC) curves. Gene set variation analysis (GSVA) and single sample gene set enrichment analysis (ssGSEA) were performed to explore the association between the signature and tumor microenvironment (TME). Two distinct subtypes associated with ICD in GC were identified, each with a different prognosis. The ICD-high expression subtype was associated with higher immune cell infiltration and a better prognosis. The ICD-related gene signature containing 11 genes (CGB5, Z84468.1, APOA5, EPHA8, CLEC18C, TLR7, MUC7, MUC15, CTLA4, CALB2, and UGT2B28), could independently and accurately predict the prognosis of GC. In this study, an ICD-based classification was conducted to assist in the diagnosis and personalized therapy for GC. The ICD-related genes risk score model was established to predict prognosis.
免疫原性细胞死亡 (ICD) 可诱导抗肿瘤免疫,并有助于瓦解免疫抑制性肿瘤微环境 (TME),它属于一种调控性细胞死亡。由于胃癌 (GC) 是一种高度异质性和侵袭性的疾病,因此对其进行亚型分化和预后标志物的发现对其治疗至关重要。然而,尽管肿瘤细胞中 ICD 的诱导与良好的预后相关,但 ICD 在 GC 中的确切作用机制仍不清楚。从癌症基因组图谱 (TCGA) 数据库中检索 GC 患者的转录组谱数据和临床数据。在此,通过共识聚类算法对患者进行分类,并根据 ICD 相关基因的表达,探索其相关的生物学功能和免疫微环境浸润。通过最小绝对收缩和选择算子回归 (LASSO) 方法建立了一个由 11 个 ICD 相关基因组成的风险评分特征。我们检索了近年来的类似研究,并使用时间依赖性接收器操作特征 (ROC) 曲线与我们的研究进行了比较。进行基因集变异分析 (GSVA) 和单样本基因集富集分析 (ssGSEA) 以探索特征与肿瘤微环境 (TME) 之间的关联。在 GC 中鉴定出两种与 ICD 相关的不同亚型,每个亚型都有不同的预后。ICD 高表达亚型与更高的免疫细胞浸润和更好的预后相关。包含 11 个基因的 ICD 相关基因特征 (CGB5、Z84468.1、APOA5、EPHA8、CLEC18C、TLR7、MUC7、MUC15、CTLA4、CALB2 和 UGT2B28) 可以独立且准确地预测 GC 的预后。在这项研究中,进行了基于 ICD 的分类以辅助 GC 的诊断和个性化治疗。建立了 ICD 相关基因风险评分模型来预测预后。